Ignite Creation Date:
2024-05-06 @ 3:46 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02374489
Status:
TERMINATED
Last Update Posted:
2018-04-05
First Post:
2015-02-23
Brief Title:
A Phase II Trial of LDK378 in ROS1 and or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma
Sponsor:
National Health Research Institutes Taiwan
Organization:
National Health Research Institutes Taiwan
Organization Data
Organization:
National Health Research Institutes Taiwan
Class:
OTHER
Study ID:
T3214
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Health Research Institutes Taiwan
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Taiwan University Hospital | OTHER |
| National Cheng-Kung University Hospital | OTHER |